Stocks · Health care · Pharmaceutical Preparations

ANAPTYSBIO, INC

ANAB Clue Score43
United States Fiscal year ends June CIK 0001370053 Results filed 12 May 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
John P. Schmid
30 Mar 2026
Director
Sell
522
$57.40
$29.96K
John P. Schmid
30 Mar 2026
Director
Sell
7,527
$56.70
$426.78K
John P. Schmid
30 Mar 2026
Director
Sell
12,596
$55.71
$701.71K
Daniel Faga
27 Mar 2026
President, CEO
Sell
100
$65.99
$6.60K
Daniel Faga
27 Mar 2026
President, CEO
Sell
3,038
$65.20
$198.07K
Daniel Faga
27 Mar 2026
President, CEO
Sell
3,155
$64.19
$202.52K
Daniel Faga
27 Mar 2026
President, CEO
Sell
2,592
$63.35
$164.20K
Daniel Faga
27 Mar 2026
President, CEO
Sell
1,012
$62.15
$62.90K
Daniel Faga
27 Mar 2026
President, CEO
Sell
550
$60.63
$33.34K
Daniel Faga
27 Mar 2026
President, CEO
Sell
490
$59.62
$29.22K
Daniel Faga
27 Mar 2026
President, CEO
Sell
3,662
$58.62
$214.65K
Daniel Faga
27 Mar 2026
President, CEO
Sell
2,570
$57.91
$148.82K
Daniel Faga
27 Mar 2026
President, CEO
Sell
510
$56.61
$28.87K
Daniel Faga
8 Jan 2026
President, CEO
Sell
14,281
$44.71
$638.50K
Eric J Loumeau
8 Jan 2026
Chief Legal Officer
Sell
2,210
$44.71
$98.81K
Dennis Mulroy
8 Jan 2026
Chief Financial Officer
Sell
2,515
$44.71
$112.45K
Paul F. Lizzul
8 Jan 2026
Chief Medical Officer
Sell
3,650
$44.71
$163.19K
Dennis Mulroy
7 Jan 2026
Chief Financial Officer
Sell
1,908
$45.11
$86.07K
Daniel Faga
7 Jan 2026
President, CEO
Sell
9,202
$45.11
$415.10K
Paul F. Lizzul
7 Jan 2026
Chief Medical Officer
Sell
2,235
$45.11
$100.82K
Eric J Loumeau
7 Jan 2026
Chief Legal Officer
Sell
500
$47.23
$23.62K
Eric J Loumeau
7 Jan 2026
Chief Legal Officer
Sell
1,841
$46.13
$84.93K
Eric J Loumeau
7 Jan 2026
Chief Legal Officer
Sell
5,281
$45.38
$239.67K
Eric J Loumeau
7 Jan 2026
Chief Legal Officer
Sell
2,017
$45.11
$90.99K
Eric J Loumeau
5 Jan 2026
Chief Legal Officer
Sell
2,983
$43.26
$129.04K
Paul F. Lizzul
5 Jan 2026
Chief Medical Officer
Sell
4,219
$43.26
$182.51K
Dennis Mulroy
5 Jan 2026
Chief Financial Officer
Sell
3,363
$43.26
$145.48K
Daniel Faga
5 Jan 2026
President, CEO
Sell
15,309
$43.26
$662.27K
J. Anthony Ware
23 Dec 2025
Director
Sell
3,900
$49.58
$193.34K
Hollings Renton
18 Jun 2024
Director
Sell
1,950
$23.16
$45.16K
Daniel Faga
25 Mar 2024
CEO
Sell
3,000
$21.42
$64.27K
Daniel Faga
22 Mar 2024
CEO
Sell
145,940
$22.78
$3.33M
Dennis Mulroy
30 Jan 2024
Chief Financial Officer
Sell
3,065
$23.63
$72.43K
Daniel Faga
8 Jan 2024
CEO
Sell
6,866
$21.81
$149.75K
Dennis Mulroy
8 Jan 2024
Chief Financial Officer
Sell
2,180
$21.81
$47.55K
Eric J Loumeau
8 Jan 2024
Chief Legal Officer
Sell
2,305
$21.81
$50.27K
Paul F. Lizzul
8 Jan 2024
Chief Medical Officer
Sell
2,554
$21.81
$55.70K
Eric J Loumeau
22 Nov 2023
Chief Legal Officer
Sell
882
$14.19
$12.52K
Dennis Mulroy
18 Sep 2023
Chief Financial Officer
Sell
3,895
$19.32
$75.24K
Eric J Loumeau
18 Sep 2023
Chief Legal Officer
Sell
3,895
$19.32
$75.23K
Eric J Loumeau
8 Aug 2022
COO, General Counsel
Sell
523
$25.00
$13.08K
Eric J Loumeau
18 May 2022
COO, General Counsel
Sell
1,146
$20.50
$23.49K
EcoR1 Capital, LLC
5 May 2022
10% owner
Sell indirect
668,237
$21.63
$14.45M
Hamza Suria
10 Jun 2019
President, CEO
Sell
454
$76.31
$34.64K
Hamza Suria
10 Jun 2019
President, CEO
Sell
1,994
$75.86
$151.27K
Hamza Suria
10 Jun 2019
President, CEO
Sell
5,000
$74.68
$373.41K
Hamza Suria
10 Jun 2019
President, CEO
Sell
6,440
$73.70
$474.64K
Hamza Suria
10 Jun 2019
President, CEO
Sell
8,540
$72.64
$620.38K
Hamza Suria
11 Dec 2018
President, CEO
Sell
4,998
$70.83
$354.01K
Nicholas Lydon
16 Apr 2018
Director
Sell
2,222
$90.26
$200.55K
Nicholas Lydon
16 Apr 2018
Director
Sell
2,803
$89.42
$250.63K
Nicholas Lydon
16 Apr 2018
Director
Sell
4,250
$88.30
$375.27K
Nicholas Lydon
16 Apr 2018
Director
Sell
9,425
$87.46
$824.34K
Nicholas Lydon
16 Apr 2018
Director
Sell
1,390
$86.15
$119.75K
Nicholas Lydon
16 Apr 2018
Director
Sell
10,310
$85.11
$877.49K
Nicholas Lydon
16 Apr 2018
Director
Sell
2,600
$84.18
$218.88K
Novo Holdings A/S
21 Aug 2017
10% owner
Sell
356,300
$21.10
$7.52M
Novo Holdings A/S
15 Aug 2017
10% owner
Sell
143,428
$21.00
$3.01M
Novo Holdings A/S
14 Aug 2017
10% owner
Sell
35,172
$21.79
$766.49K
Novo Holdings A/S
7 Aug 2017
10% owner
Sell
1,023
$22.92
$23.44K
Novo Holdings A/S
7 Aug 2017
10% owner
Sell
480,000
$21.10
$10.13M
Novo Holdings A/S
4 Aug 2017
10% owner
Sell
10,271
$22.00
$225.96K
Novo Holdings A/S
3 Aug 2017
10% owner
Sell
21,451
$22.01
$472.19K
Novo Holdings A/S
2 Aug 2017
10% owner
Sell
25,700
$23.87
$613.48K
Novo Holdings A/S
1 Aug 2017
10% owner
Sell
23,555
$23.87
$562.27K
Avalon Ventures VII L P
26 Jul 2017
10% owner
Sell indirect
37,040
$24.35
$901.92K

What was left out

Form 4 filings counted 265
Amendments (4/A) skipped 1
Filings about a different issuer 1
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 68
Sales at will 66
Transactions with no price 0
Shares from compensation/vesting 22,378,949
Sales filed before the plan box existed 26
History held since 31 Jan 2017